Carna BiosciencesTSE:4572 -3.68%29 Median PS Value is 円176.85 as of Jun. 29, 2026, which is 100% below its 10-year median of 0.71. GuruFocus rates TSE:4572 with a GF Score™ of 29/100 and a GF Value™ of 円175.60 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 277 Biotechnology companies, Carna Biosciences ranks worse than 86.64% on this metric.
This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
The historical rank and industry rank for Carna Biosciences's Median PS Value or its related term are showing as below:
TSE:4572'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.39 Med: 0.71 Max: 2.01
Current: 1.78
During the past 13 years, the highest Price to Median PS Value of Carna Biosciences was 2.01. The lowest was 0.39. And the median was 0.71.
TSE:4572's Price-to-Median-PS-Value is ranked worse than 86.64% of 277
companies
in the Biotechnology industry
Industry Median: 0.62
vs TSE:4572: 1.78
Carna Biosciences (TSE:4572) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
Carna Biosciences's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
314.00
/
176.85
=
1.78
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carna Biosciences Median PS Value Related Terms
Carna Biosciences Median PS Value Historical Data
* Premium members only.
The historical data trend for Carna Biosciences's Median PS Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4572 vs VRTX, REGN, ALNY: Median PS Value Comparison
For the Biotechnology subindustry, Carna Biosciences's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carna Biosciences Price-to-Median-PS-Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Carna Biosciences's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where Carna Biosciences's Price-to-Median-PS-Value falls into.
10-Year Median PS Ratio is 11.5906.
Carna Biosciences's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was 円15.258.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carna Biosciences (TSE:4572) has a Median PS Value of 円176.85 as of Jun. 29, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Carna Biosciences and its competitors. This is 24808% above median its historical median of 0.71. Over the past decade, Carna Biosciences' Median PS Value has ranged from 0.39 to 2.01. According to the industry distribution chart, Carna Biosciences ranks #240 out of 277 companies in the Biotechnology industry, placing it in the top 86.6%.
Is Carna Biosciences' Median PS Value too high?
Carna Biosciences' current Median PS Value of 円176.85 is 24808% above median its 10-year median of 0.71. Over the past 10 years, this metric has ranged from a low of 0.39 to a high of 2.01. Based on the distribution chart, Carna Biosciences ranks #240 out of 277 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Carna Biosciences has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Carna Biosciences' Median PS Value compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Carna Biosciences ranks #240 out of 277 companies for Median PS Value. This places Carna Biosciences in the lower half of its industry. The industry median Median PS Value is 0.62. Historically, Carna Biosciences' own Median PS Value has ranged from 0.39 to 2.01 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Biotechnology company?
The median Median PS Value among Biotechnology companies is 0.62, based on 277 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on Carna Biosciences and its competitors. For the Biotechnology industry, the median Median PS Value is 0.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carna Biosciences's current Median PS Value is 円176.85, which is 24808% above median its own 10-year median of 0.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carna Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Carna Biosciences (TSE:4572) is currently considered Significantly Overvalued. The stock's GF Value™ is 円175.60, compared to a current price of 円314.00 — trading 78.8% above its estimated fair value. The current Median PS Value is 円176.85, which is 24808% above median its 10-year median of 0.71. Carna Biosciences' overall GF Score™ is 29/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For Carna Biosciences (TSE:4572), the current Median PS Value is 円176.85 as of Jun. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Carna Biosciences (TSE:4572) Overvalued in 2026?
Based on GuruFocus' analysis, Carna Biosciences stock appears to be overvalued.
The current stock price of 円314.00 is trading 78.8% above its estimated GF Value™ of 円175.60.
GuruFocus considers Carna Biosciences to be Significantly Overvalued.
Key valuation signals for TSE:4572:
Median PS Value: 円176.85 (24808% above median its 10-year median of 0.71)
GF Value™: 円175.60 vs. price of 円314.00 (78.8% above fair value)
No single metric tells the full story. See the TSE:4572 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Carna Biosciences Inc is a Japanese company engaged in drug discovery support business and drug discovery and development business. The company identifies and develops medicines for the treatment of cancer and inflammatory diseases using own kinase drug discovery platform, QuickScout.
29GF Score
Get the complete analysis for TSE:4572
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4572 has been successfully added to your 
